Italian investigators have found that both long- and short-term results in patients aged 40 and younger appear to be excellent with PCI in individuals with premature coronary artery disease. In this analysis of 214 consecutive patients, the mortality rate was 0.0%, and the major adverse cardiac and cerebrovascular event rate was 2.3%. No additional events occurred at 30 days. At an average of 757 days follow-up, the overall death rate was 0.9%, and the rate of new revascularization procedures was 12.6%.
Abstract: American Journal of Cardiology, June 15, 2012.
